In a recent study Lin et al. investigated the anti-inflammation and anti-proliferation activity of the leptin-peptides OB3 and [D-Leu-4]-OB3 in two hepatocellular cancer (HCC) cell lines, HepG2 and Hep3B. The gene discussed is LEP; the disease is hepatocellular carcinoma.